There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Canada's Prime Minister sent a video challenge to Kensington Palace and the White House in the build up to next month's Invictus Games.
Karl, 17, was stabbed to death when his friends became involved in a row with around a gang of youths in Hackney, east London in 2004.
Researchers believe they have found the wreckage of British explorer James Cook's ship "Endeavour".